643-651
Perspectives
Open AccessTesting the theory of immune selection in cancers that break the rules of transplantation
Ariberto Fassati and N. Avrion Mitchison
653-661
Original Article
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
Hiroyuki Suzuki, Nobuhito Chikazawa, Takehiko Tasaka, Junji Wada and Akio Yamasaki, et al.
663-674
Original Article
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer
James L. Gulley, Philip M. Arlen, Ravi A. Madan, Kwong-Yok Tsang and Mary P. Pazdur, et al.
675-686
Original Article
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of Shh
Akio Yamasaki, Chizu Kameda, Rui Xu, Haruo Tanaka and Takehiko Tasaka, et al.
687-695
Original Article
Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting
Matthias May, Sabine Brookman-May, Bernd Hoschke, Christian Gilfrich and Friederike Kendel, et al.
697-706
Original Article
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine
Irina Daurkin, Evgeniy Eruslanov, Johannes Vieweg and Sergei Kusmartsev
707-713
Original Article
A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector
Weijun Zhang, Tong Zhang, Mary-Jo Turk and Edward J. Usherwood
715-727
Original Article
Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy
Eftychia Lekka, Angelos D. Gritzapis, Sonia A. Perez, Nikolaos Tsavaris and Ioannis Missitzis, et al.
729-736
Original Article
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis model
Nasreen Vohra, Monique Verhaegen, Lisa Martin, Amy Mackay and Shari Pilon-Thomas
737-746
Original Article
Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin
Robert Sarnovsky, Tara Tendler, Matheusz Makowski, Maureen Kiley and Antonella Antignani, et al.
747-757
Original Paper
Topoisomerase II alpha as a universal tumor antigen: antitumor immunity in murine tumor models and H-2Kb-restricted T cell epitope
Jung-Sun Park, Hye-Sung Kim, Mi-Young Park, Chang-Hyun Kim and Yeun-Jun Chung, et al.
759-767
Original Article
EphA2-derived peptide vaccine with amphiphilic poly(γ-glutamic acid) nanoparticles elicits an anti-tumor effect against mouse liver tumor
Shinjiro Yamaguchi, Tomohide Tatsumi, Tetsuo Takehara, Akira Sasakawa and Masashi Yamamoto, et al.
769-777
Original Article
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
Miki Tongu, Nanae Harashima, Takaya Yamada, Takayuki Harada and Mamoru Harada
779-787
Original Article
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and function
Chang-Xuan You, Yong Liu, Min Shi, Maohua Cao and Rong-Cheng Luo, et al.
789-797
Original Article
Activation of innate immunity to reduce lung metastases in breast cancer
Julie L. Jordan, A. Nowak and T. D. G. Lee
799-803
Short Communication
Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3
Cornelia L. Trimble, Shiwen Peng, Christopher Thoburn, Ferdynand Kos and T. C. Wu